Doxorubicin Paradoxically Ameliorates Tumor-Induced Inflammation in Young Mice

Doxorubicin (DOX) is one of the most widely used chemo-therapeutic agents in pediatric oncology. DOX elicits an inflammatory response in multiple organs, which contributes to DOX-induced adverse effects. Cancer itself causes inflammation leading to multiple pathologic conditions. The current study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelgawad, Ibrahim Y., Grant, Marianne K. O., Popescu, Flavia E., Largaespada, David A., Zordoky, Beshay N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396671/
https://www.ncbi.nlm.nih.gov/pubmed/34445729
http://dx.doi.org/10.3390/ijms22169023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396671/
https://www.ncbi.nlm.nih.gov/pubmed/34445729
http://dx.doi.org/10.3390/ijms22169023

Ejemplares similares